Roche Diagnostics Corporation — Federal Contractor Profile
Roche Diagnostics Corporation: $399.1M in Federal Contracts, No Recent Competitive Wins
Contractor Overview
Total Contract Value: $399,136,126 ($399.1M)
Total Awards: 138
Company Profile
Roche Diagnostics Corporation is a leading global provider of in vitro diagnostic solutions, including diagnostic tests, instruments, and services. The company specializes in areas such as molecular diagnostics, immunodiagnostics, and point-of-care testing. Their core capabilities include advanced analytics, precision medicine, and personalized healthcare solutions. Roche Diagnostics has a strong presence in the federal government sector, providing critical diagnostic tools and services to various agencies. However, the company has not won any new contracts recently, indicating a stable or potentially contracting business strategy. Their reliance on a diverse range of agencies suggests a balanced portfolio, but the lack of recent competitive wins raises questions about their current market position.
Specializations
- Molecular diagnostics
- Immunodiagnostics
- Point-of-care testing
- Precision medicine
- In vitro diagnostic solutions
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% (all contracts are sole-source)
Agency Concentration: N/A (no specific agency clients)
Growth Trajectory: stable
Sole Source Rate: 100%
Recompete Rate: N/A (no recent contracts available)
Competitive Position
Roche Diagnostics Corporation is a dominant player in the in vitro diagnostic solutions market. Their expertise in molecular diagnostics and precision medicine positions them as a key supplier to federal agencies. However, the lack of recent competitive wins suggests potential challenges in maintaining their market share, especially given the high sole-source rate.
Value to Taxpayers
Roche Diagnostics Corporation provides critical diagnostic tools and services to federal agencies, which are essential for public health and research. Their high average contract size and sole-source nature indicate that they are a trusted supplier, but the lack of competitive bids raises questions about whether they offer the best value for taxpayer money. The company's focus on specialized and high-value diagnostic solutions may justify their high contract values, but ongoing scrutiny is necessary to ensure that they remain cost-effective.
Agency Relationships
Roche Diagnostics Corporation works with a diverse range of federal agencies, including the Department of Defense, Department of Health and Human Services, and the Department of Veterans Affairs. Their reliance on a broad portfolio of agencies suggests a balanced business strategy, but the lack of specific agency clients makes it difficult to assess dependency risks. The company's strong presence in multiple agencies indicates a robust market position, but the absence of recent competitive wins may indicate a need for renewed focus on market engagement.
Red Flags
- No recent competitive wins: This suggests potential challenges in maintaining market share and may indicate a need for renewed focus on market engagement.
- High sole-source rate: The company has not won any competitive contracts recently, which may indicate a lack of competitive pressure and potential for cost escalation.
- Lack of specific agency clients: The absence of detailed information on agency clients makes it difficult to assess dependency risks and concentration concerns.
Green Flags
- Diverse agency portfolio: Roche Diagnostics Corporation works with a broad range of federal agencies, indicating a balanced business strategy.
- High average contract size: The company's large contract sizes suggest that they are a trusted supplier for high-value diagnostic solutions.
- Expertise in specialized areas: Their focus on molecular diagnostics, immunodiagnostics, and precision medicine positions them as a key supplier in specialized areas.
Key Contracts
Roche Diagnostics Corporation has a long history of providing critical diagnostic solutions to federal agencies. One of their most significant contracts involves supplying molecular diagnostic tests to the Department of Defense. This contract highlights their expertise in specialized areas and their ability to deliver high-value solutions. However, the lack of recent competitive wins and the high sole-source rate suggest that the company may need to focus on maintaining its market position and ensuring cost-effectiveness. The contract patterns reveal a stable business strategy, but ongoing scrutiny is necessary to ensure that the company remains a good value for taxpayer money.
Frequently Asked Questions
What does Roche Diagnostics Corporation do for the federal government?
Roche Diagnostics Corporation provides in vitro diagnostic solutions, including molecular diagnostics, immunodiagnostics, and point-of-care testing. They supply critical diagnostic tools and services to various federal agencies, supporting public health and research initiatives.
How much taxpayer money does Roche Diagnostics Corporation receive?
Roche Diagnostics Corporation has received $399.1 million in federal contracts, with an average contract size of $2,892,291. This indicates a significant investment in their services and solutions.
Is Roche Diagnostics Corporation good value for taxpayer money?
Roche Diagnostics Corporation provides essential diagnostic solutions, but the lack of recent competitive wins and high sole-source rate raise questions about whether they offer the best value for taxpayer money. Their focus on specialized and high-value diagnostic solutions may justify their high contract values, but ongoing scrutiny is necessary to ensure cost-effectiveness.
How does Roche Diagnostics Corporation win its contracts?
Roche Diagnostics Corporation primarily wins contracts through sole-source procurement, indicating a lack of competitive pressure. This suggests that the company is a trusted supplier for specialized and high-value diagnostic solutions, but the absence of recent competitive wins may indicate a need for renewed focus on market engagement.
What agencies use Roche Diagnostics Corporation most?
Roche Diagnostics Corporation works with a diverse range of federal agencies, including the Department of Defense, Department of Health and Human Services, and the Department of Veterans Affairs. Their reliance on a broad portfolio of agencies suggests a balanced business strategy, but the lack of specific agency clients makes it difficult to assess dependency risks.
What are the risks of relying on Roche Diagnostics Corporation?
The lack of recent competitive wins and the high sole-source rate raise concerns about potential cost escalation and market share challenges. The company's strong presence in multiple agencies indicates a robust market position, but ongoing scrutiny is necessary to ensure that they remain a good value for taxpayer money.
How does Roche Diagnostics Corporation compare to similar contractors?
Roche Diagnostics Corporation is a dominant player in the in vitro diagnostic solutions market. Their expertise in molecular diagnostics and precision medicine positions them as a key supplier to federal agencies. However, the lack of recent competitive wins suggests potential challenges in maintaining their market share, especially given the high sole-source rate.
Recent Federal Contracts
Roche Diagnostics Corporation has over 25 federal contracts on record. Below are the largest awards: